Progesterone Formulations

so / - S- Ex sg nProdo j401 0 10 20 30 40 50 60 70 Tnie WMirutes) Pharmaceutical formulations for oral use in hormone replacement therapy comprising ultra-micronized pmgesterone are disclosed, wherein the ultra-micronized progesterone is combined with a suitable excipient. The preferred excipients c...

Full description

Saved in:
Bibliographic Details
Main Authors CACACE, Janice Louise, PERSICANER, Peter H. R
Format Patent
LanguageEnglish
Published 18.06.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract so / - S- Ex sg nProdo j401 0 10 20 30 40 50 60 70 Tnie WMirutes) Pharmaceutical formulations for oral use in hormone replacement therapy comprising ultra-micronized pmgesterone are disclosed, wherein the ultra-micronized progesterone is combined with a suitable excipient. The preferred excipients comprise medium chain fatty acid-glycol esters and a nonionic surfactant comprising a polyethylene glycol fatty acid ester. In some embodiments C8 to C18 fatty acid esters of glycerol and polyethylene glycol are the preferred nonionic surfactants.
AbstractList so / - S- Ex sg nProdo j401 0 10 20 30 40 50 60 70 Tnie WMirutes) Pharmaceutical formulations for oral use in hormone replacement therapy comprising ultra-micronized pmgesterone are disclosed, wherein the ultra-micronized progesterone is combined with a suitable excipient. The preferred excipients comprise medium chain fatty acid-glycol esters and a nonionic surfactant comprising a polyethylene glycol fatty acid ester. In some embodiments C8 to C18 fatty acid esters of glycerol and polyethylene glycol are the preferred nonionic surfactants.
Author CACACE, Janice Louise
PERSICANER, Peter H. R
Author_xml – fullname: CACACE, Janice Louise
– fullname: PERSICANER, Peter H. R
BookMark eNrjYmDJy89L5WSQDCjKT08tLkktAnIV3PKLcktzEksy8_OKeRhY0xJzilN5oTQ3g4qba4izh25qQX58anFBYnJqXmpJvGOokYGhhZGRkaWJuZOTkTGRygD8PiZC
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2018222947BB2
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2018222947BB23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:13:11 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2018222947BB23
Notes Application Number: AU20180222947
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200618&DB=EPODOC&CC=AU&NR=2018222947B2
ParticipantIDs epo_espacenet_AU2018222947BB2
PublicationCentury 2000
PublicationDate 20200618
PublicationDateYYYYMMDD 2020-06-18
PublicationDate_xml – month: 06
  year: 2020
  text: 20200618
  day: 18
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies THERAPEUTICSMD, INC
RelatedCompanies_xml – name: THERAPEUTICSMD, INC
Score 3.2663949
Snippet so / - S- Ex sg nProdo j401 0 10 20 30 40 50 60 70 Tnie WMirutes) Pharmaceutical formulations for oral use in hormone replacement therapy comprising...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Progesterone Formulations
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200618&DB=EPODOC&locale=&CC=AU&NR=2018222947B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU5LNTa1SEzUNTM3twR2UAwtdBMN0hJ1gek5xcIsCZhK0kCbk339zDxCTbwiTCOYGHJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3DOofA7Ozi5Ota4C_i7-zmrMzsCep5hcEGgoEX11tYu4ELLBZQQ1p0En7rmFOoH0pBciVipsgA1sA0Ly8EiEGptQ8YQZOZ9jda8IMHL7QKW8gE5r7ikUYJAOK8tPBJxvk56UquAFbm9C7t4pFGVTcXEOcPXSBdsTDvRTvGIrkICcjYzEGFmBvP1WCQcEkySzFMAlYZSSbJAGbKmmJSaDjZVLTkkCNgTQLc0kGWbxGSRGQl2bgAoUTaLWToYUMA0tJUWmqLLBeLUmSAwcHANS1ejg
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU5LNTa1SEzUNTM3twR2UAwtdBMN0hJ1gek5xcIsCZhK0kCbk339zDxCTbwiTCOYGHJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3DOofA7Ozi5Ota4C_i7-zmrMzsCep5hcEGgoEX11tYu4ELLBZzUHn84IaT2FOoH0pBciVipsgA1sA0Ly8EiEGptQ8YQZOZ9jda8IMHL7QKW8gE5r7ikUYJAOK8tPBJxvk56UquAFbm9C7t4pFGVTcXEOcPXSBdsTDvRTvGIrkICcjYzEGFmBvP1WCQcEkySzFMAlYZSSbJAGbKmmJSaDjZVLTkkCNgTQLc0kGWbxGSRGQl2fg9Ajx9Yn38fTzlmbgAoUZaOWToYUMA0tJUWmqLLCOLUmSAwcNALPNfSU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Progesterone+Formulations&rft.inventor=CACACE%2C+Janice+Louise&rft.inventor=PERSICANER%2C+Peter+H.+R&rft.date=2020-06-18&rft.externalDBID=B2&rft.externalDocID=AU2018222947BB2